Share on StockTwits

Insmed (NASDAQ:INSM) Director Melvin Md Sharoky bought 88,889 shares of the stock in a transaction dated Wednesday, August 13th. The stock was purchased at an average cost of $11.25 per share, for a total transaction of $1,000,001.25. Following the completion of the acquisition, the director now directly owns 260,469 shares in the company, valued at approximately $2,930,276. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Insmed (NASDAQ:INSM) traded up 2.98% during mid-day trading on Thursday, hitting $13.48. The stock had a trading volume of 601,053 shares. Insmed has a 52-week low of $10.60 and a 52-week high of $22.29. The stock has a 50-day moving average of $17.03 and a 200-day moving average of $16.49. The company’s market cap is $529.5 million.

Insmed (NASDAQ:INSM) last posted its quarterly earnings results on Wednesday, August 6th. The company reported ($0.59) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.46) by $0.13. Analysts expect that Insmed will post $-1.88 EPS for the current fiscal year.

Insmed Incorporated is a biopharmaceutical company focused on patients suffering with lung diseases through the development and commercialization of targeted inhalation therapies.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.